Section: Healthcare

GlaxoSmithKline has confirmed that it will appeal against NICE’s decision earlier this month to deny NHS funding for Tyverb, a treatment for an aggressive form of advanced breast cancer

The National Institute for Health and Clinical Excellence has recommended Pfizer’s Sutent as a possible first line drug treatment for people with advanced and/or metastatic renal cell carcinoma

Measurements to improve the regulation and governance of healthcare professionals have been published in two reports from the Department of Health

Justice Holman today set out a clear process for the re-evaluation of NICE’s osteoporosis guidance following the ruling in February that the organisation had acted unlawfully by not releasing its economic model

NICE will oversee the annual reviewing of Quality and Outcomes Framework indicators for GPs from April 1.